ESR1 and breast carcinoma: For example, the estrogen receptor (ER) is a characteristic gene in breast cancer, with approximately 70%–80% of breast cancer patients being ER-positive (ER+), who typically respond well to hormone therapies such as tamoxifen (Davies et al., 2011).